GSK's Generic Flonase Antitrust Deal Gets Green Light

Law360, New York (January 15, 2013, 6:45 PM EST) -- A Pennsylvania federal judge on Monday approved a settlement between GlaxoSmithKline PLC and two groups of plaintiffs in an antitrust class action accusing the pharmaceutical giant of improperly blocking rivals from bringing generic versions of allergy medication Flonase to market.

U.S. District Judge Anita B. Brody gave preliminary approval to the deal. Terms of the settlement were not disclosed and the case has been filed under seal.

GSK spokesman Kevin Colgan said the settlement was between the drugmaker and both indirect and direct purchasers of the...
To view the full article, register now.

Related

Sections

Case Information

Case Title

IBEW - NECA LOCAL 505 HEALTH & WELFARE PLAN v. SMITHKLINE BEECHAM CORPORATION


Case Number

2:08-cv-03301

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

ANITA B. BRODY

Date Filed

July 14, 2008

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.